Clotting factor concentrates (CFC) or bypassing agents (BPA) + FITUSIRAN + ANTITHROMBIN III HUMAN

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Clotting factor concentrates (CFC) or bypassing agents (BPA) + FITUSIRAN + ANTITHROMBIN III HUMAN
Treatment and conditionWhere it standsTrials
Clotting factor concentrates (CFC) or bypassing agents (BPA) + FITUSIRAN + ANTITHROMBIN III HUMAN for hemophilia aPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2